| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/05/2001 | US20010007017 For preventing AIDS or slowing down its progression |
| 07/05/2001 | US20010006973 1-oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels |
| 07/05/2001 | US20010006966 Use of 1- (aminoalkyl) -3-quinoxaline-2-on derivatives for the preparation of compounds having an antioxidant action |
| 07/05/2001 | US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture |
| 07/05/2001 | US20010006957 Microdispersed or microfibrillar polyanhydroglucuronic acids and salts, complex salts or intermolecular polymer complexes suitable for fixing drug dosages with significantly protracted effect and reduced toxicity |
| 07/05/2001 | US20010006944 Treating noninvasive fungus-induced rhinosinusitis by mucoadministering an antifungal agent; culturing noninvasive fungus from a mammalian mucus sample for antigen/antibody production; apparatus for collecting nasal mucus |
| 07/05/2001 | US20010006816 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 07/05/2001 | US20010006815 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 07/05/2001 | US20010006814 Chemical modification |
| 07/05/2001 | US20010006806 Methods for treating sepsis |
| 07/05/2001 | US20010006799 Histidine kinase polypeptides |
| 07/05/2001 | US20010006798 Novel FtsL |
| 07/05/2001 | US20010006681 Chemokine inhibition of immunodeficiency virus |
| 07/05/2001 | US20010006667 Use and composition of an anti-sexually transmitted diseases formulation |
| 07/05/2001 | US20010006641 Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins GP300, P200, and P90/80 |
| 07/05/2001 | US20010006640 Compounds and methods to inhibit or augment an inflammatory response |
| 07/05/2001 | US20010006639 Immunogenic peptides from the HPV E7 protein |
| 07/05/2001 | CA2397952A1 Method for treatment of canine distemper |
| 07/05/2001 | CA2397710A1 Streptococcus pyogenes virulence genes and proteins and their use |
| 07/05/2001 | CA2396579A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | CA2396380A1 Improved pharmaceutical compositions for poorly soluble drugs |
| 07/05/2001 | CA2396039A1 Gfr.alpha.1-ret specific agonists and methods therefor |
| 07/05/2001 | CA2395663A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395543A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395430A1 Treatment of drug-resistant human immunodeficiency virus infection |
| 07/05/2001 | CA2395423A1 P. gingivalis antigenic composition |
| 07/05/2001 | CA2395382A1 Attenuated microorganisms for the treatment of infection |
| 07/05/2001 | CA2395335A1 Genes identified as required for proliferation of e. coli |
| 07/05/2001 | CA2395284A1 Inhibition of gsk-3.beta. |
| 07/05/2001 | CA2395275A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 07/05/2001 | CA2395173A1 Pyrrolidines which inhibit camp-specific pde |
| 07/05/2001 | CA2394880A1 Activation and inhibition of the immune system |
| 07/05/2001 | CA2394174A1 A molecular switch for regulating mammalian gene expression |
| 07/05/2001 | CA2393583A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | CA2393529A1 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | CA2363274A1 Fused-ring compounds and use thereof as drugs for hepatitis c |
| 07/05/2001 | CA2362849A1 Novel dipeptide compounds and their use as medicines |
| 07/04/2001 | EP1113020A2 Nucleosides and oligonucleotides containing boron clusters |
| 07/04/2001 | EP1113016A1 Carbapenem compounds |
| 07/04/2001 | EP1113008A1 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives useful as antibacterial and antiprotozoal agents |
| 07/04/2001 | EP1112998A1 Amine derivatives |
| 07/04/2001 | EP1112747A1 Salmonella vaccine not inducing antibodies against flagellin or flagella |
| 07/04/2001 | EP1112743A1 Nitrogenous heterocyclic carboxamide derivatives or salts thereof and antiviral agents containing both |
| 07/04/2001 | EP1112741A1 Use of protease inhibitors for the treatment of necrotizing infections |
| 07/04/2001 | EP1112692A1 Drinks and foods capable of eliminating i helicobacter pylori /i |
| 07/04/2001 | EP1112497A1 Ykl-40 as a marker and prognostic indicator for cancers |
| 07/04/2001 | EP1112366A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
| 07/04/2001 | EP1112364A2 Stomach polypeptide zsig28 |
| 07/04/2001 | EP1112362A2 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 07/04/2001 | EP1112350A2 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus |
| 07/04/2001 | EP1112269A2 Hiv protease inhibitors |
| 07/04/2001 | EP1112251A1 Azetidine derivatives, preparation and medicines containing them |
| 07/04/2001 | EP1112250A1 Therapeutic compounds and methods |
| 07/04/2001 | EP1112079A1 Myrtle extract, preparation method and use |
| 07/04/2001 | EP1112076A1 Polymeric compounds and methods of formulating same |
| 07/04/2001 | EP1112074A1 Taurolidine and/or taurultam against infectious ulcer or gastritis |
| 07/04/2001 | EP1112070A1 Novel substituted triazole compounds |
| 07/04/2001 | EP1111995A1 Topical dermal antimicrobial compositions |
| 07/04/2001 | EP0925284B1 New polycyclic phthalazin derivatives and their use |
| 07/04/2001 | EP0814776B1 Topically applied pharmaceutical composition, method of preparing it and its use |
| 07/04/2001 | EP0773956B1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same |
| 07/04/2001 | EP0679187B2 Process for recovering native, oligomeric, glycosylated ectodomains of viral membrane proteins, their use, in particular as vaccine against hiv |
| 07/04/2001 | EP0634927B1 Treatment and prophylaxis of diseases caused by parasites, or bacteria |
| 07/04/2001 | CN1302304A AZT derivatives exhibiting spermicidal and anti-viral activity |
| 07/04/2001 | CN1302297A Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in control of helicobacter bacteria |
| 07/04/2001 | CN1302290A Selective anti-mycobacterial preparations, method for producing the same and pharmaceutical compositions |
| 07/04/2001 | CN1302215A Local preparation containing poloxamer and other microbe killing agent and applicator |
| 07/04/2001 | CN1302209A Polyol-IFN-beta conjugates |
| 07/04/2001 | CN1302183A Xylitol compositions for treating upper respiratory conditions |
| 07/04/2001 | CN1301866A Full gene cloning of horse infectious anemia virus representating virus strain and its use |
| 07/04/2001 | CN1301555A Medicine for curing appendicitis and its preparing method |
| 07/04/2001 | CN1301548A Phthisis eliminating pill and phthisis eliminating liquid and their preparing method |
| 07/04/2001 | CN1067999C Anti-helicobacter heterocyclic derivatives of azolines |
| 07/04/2001 | CN1067991C Aminoalkyl substituted benzo-heterocyclic compounds |
| 07/04/2001 | CN1067986C 1H-indole-3-acetic acid hydrazide phospholipid enzyme A2 inhibitors |
| 07/04/2001 | CN1067889C Traditional Chinese Medicine compound disinfactant |
| 07/04/2001 | CN1067887C New drug for preventing and curing prawn disease and its manufacturing method |
| 07/03/2001 | USRE37263 Topically applying two solutions, gels or creams one of a metal chlorite and thickener and one of a protic acid and thickener |
| 07/03/2001 | US6255495 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups and method of application thereof |
| 07/03/2001 | US6255481 Treating aqueous suspension of anhydrous nevirapine with hydrochloric acid then treating with sodium hydroxide yields the free base as a precipitate/hemihydrate which is then filtered from solution and water washed |
| 07/03/2001 | US6255480 Aminothiazole derivatives useful in the preparation of β-lactam antibiotics |
| 07/03/2001 | US6255467 Human blood bacterium |
| 07/03/2001 | US6255453 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 07/03/2001 | US6255348 Use of aminoadamantane compounds as immunoregulators |
| 07/03/2001 | US6255335 Substituted 2-oxo-alkanoic acid-[2-(indol-3-yl)-ethyl] amides |
| 07/03/2001 | US6255318 Antiviral compounds |
| 07/03/2001 | US6255300 Aminoacylase inhibitor; therapy for bacteria infections |
| 07/03/2001 | US6255284 Pharmaceutical composition |
| 07/03/2001 | US6255100 Cyclosporin fermentation process |
| 07/03/2001 | US6255078 Nucleotide sequence which codes polypeptide associated with viral protein; for the prevention of viral infection in animals |
| 07/03/2001 | US6255072 Nucleotide sequences coding proteolytic polypeptide; for use as diagnostic tool; for the prevention of bacterial infection |
| 07/03/2001 | US6254875 Methods for use of OMP26 from Haemophilus influenzae |
| 07/03/2001 | US6254874 Attenuated auxotrophic microorganisms having a combination of non-attenuating mutations and method for making same |
| 07/03/2001 | US6254872 Protective immune response against infections |
| 07/03/2001 | US6254863 Decreasing morbidity and mortality with infection by porphyromonas |
| 07/03/2001 | CA2132512C Bioadhesive pharmaceutical composition used for the controlled release of active ingredient |
| 07/03/2001 | CA2116348C Sirs vaccine and diagnosis method |
| 07/03/2001 | CA2098108C Water dispersible tablets |
| 06/30/2001 | CA2293852A1 Procedure for preparing active plant extracts used to trap free radicals; the extracts and compounds and devices containing them |
| 06/29/2001 | CA2328781A1 Novel antibacterial and prokinetic macrolides |